InvestorsHub Logo
Followers 1
Posts 158
Boards Moderated 0
Alias Born 05/06/2019

Re: None

Tuesday, 11/17/2020 11:42:11 PM

Tuesday, November 17, 2020 11:42:11 PM

Post# of 3534
FYI PAVmed's (PAVM) CEO Lishan Aklog on Q3 2020 Results

https://seekingalpha.com/article/4389889-pavmeds-pavm-ceo-lishan-aklog-on-q3-2020-results-earnings-call-transcript

our Solys non-invasive NDIR laser-based blood glucose monitoring technology is also progressing well. We recently completed initial animal testing of a first-generation prototype and a diabetic rat model. Those results were sufficiently accurate to allow us to achieve the R&D plan milestone as defined in our license agreement. We developed a second generation prototype with dramatically improved signal-to-noise ratio, which should be ready for human volunteers testing in that front.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KNW News